SBI-115 is primarily used in biomedical research as a selective inhibitor targeting specific cellular pathways involved in cancer progression. It has shown potential in modulating protein-protein interactions that are critical for tumor cell survival and proliferation. Due to its ability to cross cell membranes effectively, SBI-115 is employed in studies focused on intracellular signaling mechanisms, particularly in hematological malignancies. Researchers utilize it to probe the function of specific oncogenic proteins and assess downstream effects on apoptosis and cell cycle regulation. Its application supports the development of targeted therapies, especially in cancers where conventional treatments have limited efficacy.